Morning Brief
BioCryst Pharmaceuticals, Inc. (BCRX) Stock Nose-Diving in Regular Market, Here’s Why
BioCryst Pharmaceuticals, Inc. (BCRX), a biotechnology company, is trading at $11.64 in the current market after plunging 34.90% since the start of the trading session.
